<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    SCYNEXIS, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About SCYNEXIS, Inc.

    SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $84,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marco Taglietti, M.D.
    • FOUNDED
      1999
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    vTv Therapeutics Inc.

    vTv Therapeutics Inc.

    vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the disc...

    vTv Therapeutics is a clinical-stage biopharmac...

    Filing Type:    PU
    Ourotech, Inc.

    Ourotech, Inc.

    A patient that is diagnosed with cancer today will have a genetic screen on their ...

    A patient that is diagnosed with cancer today w...

    Fundraising Status:    SD
    Filing Type:    CF
    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into ...

    Sangamo Therapeutics, Inc. is focused on transl...

    Filing Type:    PU

    Predictive Oncology Inc.

    Predictive Oncology is a clinical and translational data pipeline and AI-driven pl...

    Predictive Oncology is a clinical and translati...

    Filing Type:    PU
    Halo Cures, Inc.

    Halo Cures, Inc.

    Halo gives scientists and academics opportunities to connect with industry partner...

    Halo gives scientists and academics opportuniti...

    Filing Type:    CF
    Illusio, Inc.

    Illusio, Inc.

    ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to...

    ILLUSIO is a plastic surgery simulation tool th...

    Fundraising Status:    EC
    Filing Type:    CF
    Affimed Therapeutics

    Affimed Therapeutics

    At Affimed, we are committed to improving outcomes for patients with cancer. Our s...

    At Affimed, we are committed to improving outco...

    Filing Type:    PU
    CytoDyn Inc.

    CytoDyn Inc.

    CytoDyn is a publicly traded late stage biotechnology company developing innovativ...

    CytoDyn is a publicly traded late stage biotech...

    Filing Type:    PU
    Insitu Biologics, Inc

    Insitu Biologics, Inc

    InSitu Biologics is an emerging biotech company focusing on development of AnestaG...

    InSitu Biologics is an emerging biotech company...

    Amount Raised:    $2,000,000.00
    Fundraising Status:    EC
    Filing Type:    RA
    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical compan...

    Spero Therapeutics, Inc. is a multi-asset, clin...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.